BioSpace News Archive

BioAtla, Inc. (Nasdaq: BCAB) today announced that it plans to host a conference call and webcast on Thursday, November 3, 2022 at 4:30 p.m. ET to discuss its financial results for the quarter ended September 30, 2022 and provide business highlights.

Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) today announced that it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Thursday, November 3, 2022, to provide a corporate update and discuss details of the Company’s financial results for the quarter ended September 30, 2022.

Myeloid Therapeutics, Inc. (“Myeloid”), a clinical-stage mRNA-immunotherapy company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to MT-101 in patients with refractory or relapsed CD5+.

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the third quarter of 2022.

Sonoma Pharmaceuticals, Inc. announced that it has launched Reliefacyn® Advanced Itch-Burn-Rash-Pain Relief Hydrogel and Rejuvacyn® Advanced Skin Repair Cooling Mist direct to consumers for over-the-counter use in the United States.

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, announced that it will host its first virtual ESG Day for analysts and investors at 9:00 a.m. ET on Thursday, November 10.

enVVeno Medical Corporation, a company setting new standards of care for the treatment of venous disease, provided a corporate update and reported financial results for the third quarter ended September 30, 2022.

According to Latest Report Study, the global autologous cell therapy market is predicted to surpass around USD 34.94 billion by 2030 with a CAGR of 18.13% from 2022 to 2030.

Latest Study on “AI In Cancer Diagnostics Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2022-2030”.

According to Vision Research Reports, the global proteinase K market size was garnered at USD 3.7 billion in 2021 and is expected to hit around USD 7.98 billion by 2030, growing at a CAGR of 8.92% from 2022 to 2030.